This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Posteruptive colour changes of dental hard tissues
K11_COLOR_ERUPTIVE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
17 |
4. Check minimum number of eventsNone |
17 |
5. Include endpointsNone |
17 |
6. Filter based on genotype QC (FinnGen only) |
17 |
Control definitions (FinnGen only)
- Control exclude
- K11_ORAL
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Posteruptive colour changes of dental hard tissues
based on the number of shared cases.
Similar with more cases:
- Other diseases of hard tissues of teeth
- Diseases of oral cavity, salivary glands and jaws
- Gastrointestinal diseases
- Factors influencing health status and contact with health services
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 78 | 38 | 38 |
| Only index persons | 57 | 33 | 24 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 20.07 | 21.41 | 16.62 |
| Only index persons | 26.31 | 23.43 | 30.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 17 | 12 | 5 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | 21.82 | 26.39 | 10.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
0
+∞
6.65
5.0
0.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
8
13
10.48
4.07
4.0
1.8
e9/l
61.3
82.5
—
8
7
(3007853) Bacteria identified in Skin by Aerobe culture
8
15
8.99
3.73
4.0
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
9
21
7.84
3.66
4.2
2.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
7
11
9.88
3.60
37.4
9.6
mg/l
1.2
1.1
—
7
11
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
14
7.65
3.11
3.4
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
10
8.54
2.98
21.8
2.1
mmol/l
24.6
23.2
—
6
10
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
22
5.89
2.81
16.4
2.2
s
29.0
29.7
—
8
22
(3005719) IgG [Mass/volume] in Serum or Plasma
5
7
9.47
2.74
2.0
3.3
g/l
6.1
9.2
—
5
7
(3000494) Fungus identified in Specimen by Culture
5
7
9.47
2.74
2.4
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
45
5.04
2.69
16.4
3.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
8
24
5.34
2.60
9.3
3.4
%
1.3
1.5
—
8
24
(3036489) Thrombin time
5
8
8.25
2.55
16.6
2.4
s
21.6
23.8
—
5
8
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
8
8.25
2.55
16.4
2.4
%
174.4
190.5
—
5
8
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
8
8.25
2.55
17.8
2.3
g/l
2.7
2.4
—
5
8
(3000991) Gas panel - Venous blood
8
25
5.09
2.50
34.6
7.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
26
4.86
2.41
25.0
3.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
14
5.98
2.39
15.8
2.1
%
95.5
83.1
—
6
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
9
7.31
2.39
1.8
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
9
7.31
2.39
23.6
2.3
g/l
106.8
137.3
—
5
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
9
7.31
2.39
5.6
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
8
28
4.46
2.23
12.6
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10
43
4.18
2.08
12.1
2.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
7
23
4.42
2.08
8.4
2.7
umol/l
254.9
302.1
—
7
23
(3015736) pH of Urine
10
45
3.93
2.01
11.3
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
8
31
3.95
1.99
10.4
2.2
e6/l
4.5
5.7
—
8
31
(3041096) Erythrocytes [Presence] in Urine by Automated
8
31
3.95
1.99
5.6
3.1
—
—
—
0
0
(3012544) pH of Venous blood
8
31
3.95
1.99
36.3
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
8
31
3.95
1.99
35.9
3.2
mmol/l
1.1
0.8
—
8
19
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
19
4.28
1.85
1.8
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
33
3.66
1.84
5.0
2.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
9
38
3.87
1.83
12.7
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
11
56
3.70
1.82
31.6
3.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
28
3.52
1.68
35.3
12.1
mmol/l
24.3
25.0
—
7
28
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
7
29
3.37
1.61
48.7
7.9
mmol/l
1.7
1.5
—
7
20
(3042936) Bacteria identified in Isolate by Culture
5
16
3.97
1.56
4.4
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
23
3.45
1.53
1.8
2.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
8
39
2.96
1.40
25.4
4.9
%
96.3
86.7
—
8
39
(3020564) Creatinine [Moles/volume] in Serum or Plasma
17
135
+∞
1.34
46.8
9.9
umol/l
74.3
62.5
0.58
17
135
(3044640) Blood type and Crossmatch panel - Blood
9
47
2.92
1.32
5.3
2.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
10
60
2.60
1.17
7.1
3.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
6
27
2.87
1.06
37.3
8.1
mmol/l
24.2
24.6
—
6
27
(3022313) Gas panel - Capillary blood
6
27
2.87
1.06
45.0
8.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
6
28
2.75
1.04
14.3
1.7
mg/l
2.3
1.2
—
6
20
(40761511) CBC panel - Blood by Automated count
17
144
+∞
0.87
43.1
7.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7
43
2.06
0.79
2.3
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
9
58
2.16
0.74
16.2
5.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
6
35
2.09
0.67
4.2
2.1
mg/l
2.6
2.4
—
6
30
(3026008) Bacteria identified in Urine by Culture
7
46
1.88
0.59
7.4
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
11
83
1.92
0.51
23.4
4.0
e9/l
0.0
0.0
0.00
11
61
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
0
16
0.00
0.43
0.0
1.4
—
1.1
—
0
5
(3010813) Leukocytes [#/volume] in Blood
17
154
+∞
0.43
68.1
14.8
e9/l
7.2
7.3
0.05
17
149
(3000963) Hemoglobin [Mass/volume] in Blood
17
154
+∞
0.43
68.1
15.2
g/l
124.6
132.4
1.49
17
154
(3026361) Erythrocytes [#/volume] in Blood
17
153
+∞
0.43
68.2
14.9
e12/l
4.2
4.5
1.97
17
148
(3024731) MCV [Entitic volume]
17
153
+∞
0.43
67.8
14.8
fl
90.5
88.2
0.67
17
153
(3035941) MCH [Entitic mass]
17
153
+∞
0.43
67.8
14.8
pg
30.4
29.6
0.67
17
153
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
0
18
0.00
0.42
0.0
1.2
—
51.6
—
0
9
(3003694) ABO and Rh group [Type] in Blood
6
47
1.42
0.24
1.8
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
5
42
1.27
0.11
2.0
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
8
72
1.21
0.10
4.6
2.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
106.6
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
18.7
—
0
9
(3022621) pH of Urine by Test strip
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
18.9
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
380.2
—
0
5
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
7.5
—
204.2
—
0
6
(3028300) Cannabinoids [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000492) Spirometry study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4010399)
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_COLOR_ERUPTIVE and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_COLOR_ERUPTIVE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_COLOR_ERUPTIVE – Posteruptive colour changes of dental hard tissues
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data